Potential clinical impact of T-cell lymphocyte kinetics monitoring in patients with B cell precursors acute lymphoblastic leukemia treated with blinatumomab: a single-center experience.

Duminuco A, Markovic U, Parrinello NL, Lo Nigro L, Mauro E, Vetro C, Parisi M, Maugeri C, Fiumara PF, Milone G, Romano A, Di Raimondo F, Leotta S

Open source

DOI
10.3389/fimmu.2023.1195734
Published
2023
Container
Frontiers in immunology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fimmu.2023.1195734,
  title = {Potential clinical impact of T-cell lymphocyte kinetics monitoring in patients with B cell precursors acute lymphoblastic leukemia treated with blinatumomab: a single-center experience.},
  author = {Duminuco A and Markovic U and Parrinello NL and Lo Nigro L and Mauro E and Vetro C and Parisi M and Maugeri C and Fiumara PF and Milone G and Romano A and Di Raimondo F and Leotta S},
  year = {2023},
  journal = {Frontiers in immunology},
  doi = {10.3389/fimmu.2023.1195734},
  url = {https://doi.org/10.3389/fimmu.2023.1195734}
}

RIS

TY  - JOUR
TI  - Potential clinical impact of T-cell lymphocyte kinetics monitoring in patients with B cell precursors acute lymphoblastic leukemia treated with blinatumomab: a single-center experience.
AU  - Duminuco A
AU  - Markovic U
AU  - Parrinello NL
AU  - Lo Nigro L
AU  - Mauro E
AU  - Vetro C
AU  - Parisi M
AU  - Maugeri C
AU  - Fiumara PF
AU  - Milone G
AU  - Romano A
AU  - Di Raimondo F
AU  - Leotta S
PY  - 2023
JO  - Frontiers in immunology
DO  - 10.3389/fimmu.2023.1195734
UR  - https://doi.org/10.3389/fimmu.2023.1195734
ER  - 

APA

A, D., U, M., NL, P., L, L. N., E, M., C, V., M, P., C, M., PF, F., G, M., A, R., F, D. R., & S, L. (2023). Potential clinical impact of T-cell lymphocyte kinetics monitoring in patients with B cell precursors acute lymphoblastic leukemia treated with blinatumomab: a single-center experience.. Frontiers in immunology. https://doi.org/10.3389/fimmu.2023.1195734

Source records